Cancer cell adaptation to chemotherapy

Tumor resistance to chemotherapy may be present at the beginning of treatment, develop during treatment, or become apparent on re-treatment of the patient. The mechanisms involved are usually inferred from experiments with cell lines, as studies in tumor-derived cells are difficult. Studies of human...

Full description

Saved in:

Bibliographic Details
Published in:	BMC cancer Vol. 5; no. 1; p. 78
Main Authors:	Di Nicolantonio, Federica, Mercer, Stuart J, Knight, Louise A, Gabriel, Francis G, Whitehouse, Pauline A, Sharma, Sanjay, Fernando, Augusta, Glaysher, Sharon, Di Palma, Silvana, Johnson, Penny, Somers, Shaw S, Toh, Simon, Higgins, Bernie, Lamont, Alan, Gulliford, Tim, Hurren, Jeremy, Yiangou, Constantinos, Cree, Ian A
Format:	Journal Article
Language:	English
Published:	England BioMed Central 18.07.2005 BMC
Subjects:	Antineoplastic Agents - pharmacology ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism Biopsy Camptothecin - analogs & derivatives Camptothecin - pharmacology Cell Line, Tumor Cisplatin - pharmacology Down-Regulation Doxorubicin - pharmacology Drug Resistance, Neoplasm Drug Therapy - methods Epirubicin - pharmacology Fluorouracil - pharmacology Gene Expression Regulation, Neoplastic Humans Immunohistochemistry Neoplasms - drug therapy Paclitaxel - pharmacology Recurrence Reverse Transcriptase Polymerase Chain Reaction Time Factors Topotecan - pharmacology Treatment Outcome Up-Regulation
ISSN:	1471-2407, 1471-2407
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!